drugset / Trial / NCT00701740
Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial
RandomizedParallel-groupSingle-blindTreatment
Summary
A clinical and histological randomized controlled phase II trial to evaluate the efficacy and safety of oral isotretinoin for treating photoaging was performed with 32 menopausal or sterilized women aged 40-55y. The subjects were included in two randomly selected groups: A- 21 women received 20mg oral isotretinoin 3x week, moisturizer, sunscreen SPF 60 during three months; B- 11 women received only same moisturizer/sunscreen.
Timeline
- Start
- 2007-07
- Primary completion
- 2008-01
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Isotretinoin | Other / unclassified | 20 mg | Oral |
| Comparator | Mexoryl SX / XL | Unknown | — | — |
Indications
No indication recorded.